Date post: | 12-Jan-2017 |
Category: |
Health & Medicine |
Upload: | gmch-nagpur |
View: | 74 times |
Download: | 1 times |
Sarcoidosis Dr. Sagar A Gandhi
Resident Department of pulmonary medicine
GMCH , Nagpur
Introduction
• Jonathan Hutchinson was the first to describe a case of sarcoidosis in 1887;
• He called it Mortimer’s malady, after one of his patients who presented with face and limb skin lesions.
Sarcoidosis is a multisystem disorder of unknown
etiology characterized by non caseating granuloma
which affects mainly lungs but can also occur in other
organs .
Caseating granulomasTB
Non caseating granulomasSarcoidosis
Epidemiology • It occurs mainly in 3rd or 4th decade of life
• > 80 % cases in age group 20 – 50 yrs
• Prevalence is 10 to 40 cases / 100000.
• Persistent disease with greater mortality found in blacks and women .
• Mortality is 1 to 5 %
Etiology and Pathogenesis• Remains unknown, but several lines of evidence suggest that it is a
disease of disordered immune regulation in genetically predisposed individual.
• The mycobacterial catalase-peroxidase protein (mKatG) is a pathogenic antigen.
• Other mycobacterial antigens including . mKatG, . Mycobacterium tuberculosis ESAT-6, . Ag85, . superoxide dismutase
Etiology and Pathogenesis
Also suspected of having a causative role are Borrelia burgdorferriChlymadia pneumoniaRickettsia
VirusesEBV,CMV, HHV-6, HTLV 1 :::::> B cell activation
Etiology and Pathogenesis
Genetic factorsAssociated with HLA class I, HLA B8, HLA-DR3,HLA-DR B1-1101, HLA-DRB1-1501
Not associated withNon HLA, ACE , Vit D, HLA DR1 , HLA DR4, HLA DR17
T cells, Macrophages
Chemoattractants Growth Factors
Cellular proliferation Granuloma
Fibrosis
Overall Pathogenesis
Pathogenesis• These process are driven by CD4+T Cell.• Increase levels of T-cell derived TH 1 cytokines.
• The antigenic triggering agents cause activation of the Helper T-cell and Macrophages.
• Activated Helper T-cell and Macrophages produce IL-2, IFN and TNF.
• complex interaction of cytokines cause Inflammatory response leading to granuloma.
Pathogenesis
Pathophysiology• Granulomas are Pathologic hall mark of sarcoidosis.
• Giant cells are collection of fused Macrophages-Langerhans giant cells found in the central part of the granuloma
• The central epithelioid and giant cells are surrounded by a rim of lymphocytes,
mostly T-helper cells
Histologically
• All involved tissues show the classic well formed non-caseating granuloma.
• composed of an aggregates of tightly clustered epithelioid cell with langerhans or foreign body giant cell.
• central necrosis is unusual.
• With chronicity the granulomas may become enclosed within fibrous rimes or may be eventually be replaced by hyaline fibrous scars.
LANGHANS' GIANT CELL
Langhans' giant cell in center of granuloma is surrounded by epithelioid cells
Asteroid bodiesstellate inclusion enclosed with in giant cells are formed in
approximately 60% of granulomas
Asteroid bodies
Asteroid bodies
CYTOPLASMIC INCLUSION BODY Schaumann body (arrow)
laminated concentration composed of calcium and proteins
ADVANCED COLLAGENOUS FIBROSIS Elongated fibroblasts (FB) with extensive collagenous tissue
(C). Giant cells (arrows)
Systems affected by sarcoidosisSystems Percentage
Pulmonary 90%Lymph nodes 70%Hepatic 50-80%Cardiac 30%Cutaneous 25%Ocular 20%Spleen 18%Bones 14%Neurogenic 5%
C.PSarcoidosis
Asymptomatic 50%
Respiratory symptoms
Cough
Dyspnea
expectoration
Constitutionalsymptoms
Fatigue
Weight loss
Night sweats
Erythema nodosum
Pulmonary sarcoidosis
Pulmonary Sarcoidosis• It is the First site of involvement.
• Begin with alveolitis involving small bronchi and small blood vessels.
• Alveolitis either clear up spontaneously or lead to granuloma or fibrosis.
Pulmonary Sarcoidosis
Microscopically..
There is usually no demonstrable alteration , although in advanced cases granuloma produce small nodule that are palpable or visible as 1 to 2 cm noncaseating, noncavitary consolidation.
Pulmonary Sarcoidosis
Histologically.• The lesion are distributed primarily along the lymphatics,
around the bronchi and blood vessels.Although alveolar lesion are also seen in relative frequency.• The granulomas in the bronchial sub mucosa account for
the high diagnostic yield of bronchoscopic biopsy.• There seems to be a strong tendency for lesion to heals in
the lungs, so varying stages of fibrosis, hyalinization are not found.
CASEOUS NECROSISCellular destruction in TB granuloma appears as clumped debris
(arrows). This necrosis does not occur in sarcoidosis.
Noncaseating granuloma in lung is the characteristic lesion of sarcoidosis.
SUBPLEURAL GRANULOMA IN LUNG
Paradoxical response
One of the distinguishing features of sarcoidosis.As the lung disease worsens, the nodal enlargement usually regresses.
Nodal enlargementLung disease
Parenchymal sarcoidosisTypical
Interstitial micro-nodules
Fibrosis
Atypical Pulmonary nodules &
masses
Consolidation
Ground glass opacification
Linear reticular opacities
Fibrocystic changes
Miliary opacities
Airway involvement
Pleural disease
InterstitiumCentral
Peribronchovascular
PeripheralInterlobu
larSubpleur
al
Bilateral perihilar predominance
Atypical parenchymal sarcoidosisMilliary opacities
CT shows well defined lung nodules less than 5mm in diameter.
Rare 1%
ALVEOLAR SARCOIDOSIS Multiple lung masses are an unusual form of
Sarcoidosis, resembles lung metastases.
Atypical parenchymal sarcoidosisLinear reticular opacities
15-20%
Atypical sarcoidosisPulmonary consolidation
10-20%
PNEUMONIC APPEARANCE Confluent acinar opacities look similar to pneumonic
consolidation.
Atypical parenchymal sarcoidosisPulmonary nodules or masses
15-25 %
Sarcoid Galaxy sign
NODULAR PATTERN Small 5mm nodules are subpleural, along fissures and bronchovascular bundles. Give the vessels (arrow) and
fissures a beaded appearance.
Nodular thickening of the peri-broncho-vascular interstitium
Sub-pleural nodules
Fissure nodules
Lymph nodes with rim (eggshell) calcification are rare in sarcoidosis but common in silicosis.
Atypical parenchymal sarcoidosisPatchy ground glass opacities
40%
Pleural disease
Rare < 1%• Pleural effusion.• Hemothorax.• Chylothorax (due to involvement of the mediastinal LN or thoracic duct).
Air way involvement
• May occur at any level• Bronchial wall thickening• Luminal abnormalities• Obstruction of lobular or
segmental bronchi• Mosaic perfusion• Air-trapping on
expiration
Air trapping seen on expiration
I II
III IV
STAGE I Thoracic Lymphadenopathy.
Normal lung parenchyma. (50%)
STAGE II Hilar and mediastinal Lymphadenopathy.
Abnormal lung parenchyma. ( 30% )
STAGE III pulmonary infiltrates with No Lymphadenopathy.
STAGE IV Extensive pulmonary fibrosis is typically worst in the
upper lobes.
Upper lobe predominance
STAGE IV Broad bands of fibrosis in the upper lobes
STAGE IV Permanent lung fibrosis. (20%)
MOST COMMON PATTERN Bilateral symmetric hilar and right paratracheal
mediastinal adenopathy.
Differential Diagnosis of Noncaseating Granulomas
TBFungal infectionsLymphomaEpithelioid tumors of the breastLung cancer
Clinical Presentation– Most patients have the pulmonary manifestations, most commonly presenting with incidental findings on
CXR.
– Interstitial disease
– Symptoms include dry cough, dyspnea, and chest discomfort
– Unpredictable course
PROGNOSIS OF PULMONARY SARCOIDOSIS
Prognosis of pulmonary sarcoidosis
3/4
Complete resolution of
hilar lymphadenopathy
1/3
Complete resolutionof
parenchymaldisease
1/5
Irreversiblepulmonary
fibrosis
LYMPH NODES sarcoidosis
Sarcoidosis of Lymph nodesLymph nodes are involved in almost all cases
particularly the hilar and medistinal nodes.
Any other nodes may be involved.
Nodes are characteristically enlarged discrete and sometimes calcified.
Tonsil may affected in about quarter to one third of the cases
Lymphadenopathy
Lymphadenopathy Typical
Bilateral hilar & right paratracheal LN. Middle mediastinal LN occur in 50% of cases.
Left paratracheal, aorto-pulmonary & subcarinal LN.
1-2-3 sign present in 95% of cases. This is called Garland triad
Differential Diagnosis ofbilateral hilar LN
Granulomatous infectionsTBHistoplasmosisCoccidiomycosisAutoimmune disordersMalignancy (Lymphoma)
Lymphadenopathy
Lymphadenopathy
Lymphadenopathy
Lymphadenopathy
Enlarged bilateral hilar, right paratracheal (arrow), and aortopulmonary window (arrowhead) nodes.
Lymphadenopathy Atypical
Unilateral hilar LN.
Anterior or posterior mediastinal LN.
LN calcification (amorphus, punctate, popcorn or eggshell calcification).
DD of calcified hilar or mediastinal LN
• Silicosis• Sarcoidosis.• TB.• Treated lymphoma.
Calcified hilar & mediastinal LN
Calcified hilar & mediastinal LN
PARACARDIAC LYMPH NODE
ABDOMINAL LYMPHADENOPATHY Multiple enlarged paraaortic, paracaval, and porta
hepatis lymph nodes (arrows).
CUTANEOUS sarcoidosis
Skin 33% have skin lesions
Cutaneous anergy is common.
NAKED GRANULOMA Young granulomas (arrows) in the skin with no
surrounding rim of mononuclear cells.
ERYTHEMA NODOSUM These reddish raised lesions
Erythema Nodosum
Erythema nodosum
Lofgren syndrome• Acute sarcoidosis characterized by triad • Also lupus pernio is never present in lofgren syndrome
Lofgren syndrome
Bilateral hilar
lymphadenopathyArthritis Erythema
nodosum
Skin Lupus pernio- by besnier
• indurated blue purple swollen shiny lesions on nose, cheeks, lips, ears and fingers.
• Papules, nodules, and plaques
• Psoriatic like lesions
• Lesions in scars and tattoos
LUPUS PERNIO Facial lesions are most common, but the extremities
and buttocks can be involved.
LUPUS PERNIO Indurated and violaceous range from a few small lesions to large
lesions
PSORIASIS LIKE LESIONS These small white lesions closely resemble psoriasis.
OCCULAR sarcoidosis
Eyes25% have eye lesions
Blurred vision, pain, photophobia and dry eyes
Chronic uveitis leads to glaucoma, cataracts and blindness
Keratoconjunctivitis sicca
Papilloedema
CONJUNCTIVITIS
PAPILLEDEMA Often associated with 7th nerve facial palsy.
Sarcoid Choreoretinitis
Heerfordt’s syndrome
• Acute sarcoidosis characterized by uveoparotitis
Heerfordt’s syndrome
Uveitis Parotitis Facial palsy
Heerfordt’s syndrome
Bilateral parotitis
Panda sign
• Bilateral lacirmal gland, parotid gland & normal nasopharyngelal uptake on
Ga-67 scintigraphy.
LIVER sarcoidosis
Liver• 33% have hepatomegaly or biochemical
evidence of disease
• Symptoms usually absent
• Cholestasis, fibrosis, cirrhosis, portal hypertension, and the Budd-Chiari syndrome have been seen
SPLEEN & LIVER GRANULOMAS The small low attenuation lesions in the liver and spleen
in sarcoidosis.
MUSCULOSKELETAL SARCOIDOSIS
Musculoskeletal sarcoidosis
•Arthralgia (Lofgren syndrome).Joints•Myopathic type•Nodular type.Muscles• Lace like lytic lesion +
(tendosynovitis).• Cytic lesions.• Sclerotic lesions.
Osseous sarcoidosis
Arthritis Acute polyarthritis with fever is common
Arthritis is self limited
Polymyositis and chronic myopathy
Chronic destructive bone disease with deformity is rare
Musclar nodular sarcoidosis
Low signal intensity centre due to fibrosis.
Sarcoid dacytilits
• Tenosynovitis + lace like lytic lesion
LACY TRABECULAR PATTERN Osteolysis has left a lacy trabecular pattern in this
phalanx (arrow)
PUNCHED OUT LYTIC LESIONS Focal osteolytic lesions in the fingers are most
common abnormality.
SCLEROTIC LESION Rare and often in the axial skeleton.
NERVOUS SYSTEM
SARCOIDOSIS
Neurosarcoidosis• Periventricular white matter lesions• Enhancing nodules or massesParenchymal S
• Dural masses.• Diffuse dural thickeningPachymeningeal S
• Basal cisterns.• Cerebral sulci or cerebellar fissures.• Virchow Robin perivascular spaces.
Leptomeningeal S
• Thickening & enhancement.Pituitary / hypothalamic S
• Optic nerves.• Facial nerves.Cranial nerve S
• Osteolytic lesion with well defined non sclerotic margin.Calvarial sarcoidosis
Nervous SystemCranial nerves, and peripheral nerves can be
involved
7th nerve facial palsy is most common
Acute, transient, and can be unilateral or bilateral
KIDNEY SARCOIDOSIS
KidneyGranulomatous interstitial nephritis produces
renal failure
Develops over a period of weeks to months
Rapid response to steroid therapy
Kidney stones (nephrolithiasis) and nephrocalcinosis are very unusual
secondary to hypercalcemia and hypercalciuria
KidneyIncreased calcium absorption in the gut
Related to high levels of circulating 1,25-dihydroxy vitamin D produced by
mononuclear phagocytes in granulomas
GASTRIC SARCOID Granuloma involves the gastric antrum leading to
irregular nonspecific narrowing.
COLONIC SARCOID Irregular narrowing of the rectosigmoid has the
appearance of inflammatory disease or malignancy.
Lab Abnormalities Lymphocytopenia
Mild eosinphilia
Increased E.S.R
Hyperglobulinemia
Lab AbnormalitiesElevated level of angiotensin converting enzyme(ACE)
Bronchioalveolar lavage shows increased lymphocytes
Lab Abnormalities• ACE levels elevated 60- 80%.
• Activated macrophages produce ACE.
• Non Specific- Also in Hodgkins,histoplasma,leprosy • ACE levels tested regularly to check the severity of
the disease and to monitor the response to therapy.
Lung Function TestMay be normal
Restrictive pattern DLCO, FEV1, FVC
Obstructive impairment in advanced fibrocystic disease Bronchial hyperresponsiveness responding to
bronchodilator therapy
DiagnosisIdentify noncaseating granulomas.
Variety of infections.
Difficult to differentiate from chronic infections, fungal diseases, T.B. and lymphoma.
Based on combined Clinical + radiological + histological findings.
DiagnosisTransbronchial biopsies positive in 65-95%, even if no lung parenchymal abnormalities imaged.
Tissue from mediastinoscopy positive in 95%
Scalene node biopsy positive in 80%
DiagnosisKVEIM TEST
Involves injecting standardized preparation of sarcoid tissue material into the skin.
Unique lump formed at the point of injection is considered positive for sarcoidosis.
Kveim test - skin biopsyNon-necrotizing granulomas
Prognosis
• Good• In 15-20% remains active or reccurs
intermittently. • 50% have some permanent organ
dysfunction
ADENOPATHY AT TIME OF DIAGNOSIS Marked enlarged hilar and mediastinal lymph nodes.
ADENOPATHY DECREASED 2 YRS LATER Lymph nodes are smaller and there is parenchymal
lung disease.
Treatment• No known cure• Corticosteroids, primary treatment for
inflammation and granuloma formation.• Prednisolone, 1 mg/kg for 4-6 weeks
followed by slow taper over 2-3 months.• Mostly given for 6 to 24 months• Early taper results in relapse• Inhaled steroid limited effect• 20 % reccurance
Treatment
Cutaneous Sarcoidosis-
Topical steriods/Hydroxychloroquine.
Chloroquine in lupus pernio
IMMUNOSUPPRESANTS• Methotrexate - Prednisolone not
tolerated/not effective/steriod sparing agent.
• MTX –Start with 10mg/week and maintain with 2.5 to 15mg/week.
• CBC,KFT,LFT/2months.
Treatment
ANTI-TNF • Infliximab• Etanercept• Adalimumab
THANK YOU